AbCellera secures COVID-19 drug development funding

By The Science Advisory Board staff writers

May 4, 2020 -- AbCellera Biologics has secured $175.6 million Canadian ($124.7 million U.S.) from the Canadian government's Innovation, Science, and Economic Development Strategic Innovation Fund to advance its efforts to discover antibodies for use in antiviral COVID-19 drugs.

The company developed an antibody discovery platform to search blood samples of people who have recovered from COVID-19. In a collaboration with the U.S. National Institutes of Health, it has identified more than 500 anti-SARS-CoV-2 antibodies since February 25.

Under phase I of the Canadian collaboration, AbCellera will improve its antibody discovery platform for finding COVID-19 antibodies, while under phase II, it will build a new good manufacturing practice (GMP) facility in Vancouver to produce antibodies from patient samples for clinical trials.

AbCellera recently announced a partnership with Eli Lilly to develop a COVID-19 treatment, with clinical trials beginning in July, it said.

Researchers investigate how a potent mAb blocks SARS-CoV-2
Based on previous research that explored therapies against SARS-CoV, a new report has identified a fully human monoclonal antibody (mAb) that prevents...
Valo to develop pancoronavirus vaccine
Valo Therapeutics announced that it is working on the development of a potential COVID-19 vaccine with applications across future pandemics.
WHO cautions against coronavirus 'immunity passports'
The World Health Organization (WHO) has published a report expressing caution about the value of antibody tests for the novel coronavirus and saying that...
Experts discuss promising strategies for tackling SARS-CoV-2
What's the best strategy for developing treatments for the SARS-CoV-2 virus? The most promising approaches for a rapid response are antivirals and gene...
COVID-19 vaccine candidates show progress amid challenges
As the COVID-19 outbreak advances worldwide, companies are stepping up to the challenge to develop a potential vaccine. There are over 75 confirmed COVID-19...

Copyright © 2020 scienceboard.net


Conferences
BioProcess International (BPI) Conference
September 27-30
Boston, Massachusetts United States
Laboratory Products Association Annual Meeting
October 1-4
Scottsdale, Arizona United States
Cell & Gene Meeting on the Mesa
October 11-13
Carlsbad, California United States
IDWeek 2022
October 19-23
District of Columbia United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter